The Effect of Plant Sterol Supplement on Blood Cholesterol
NCT ID: NCT00485095
Last Updated: 2011-07-01
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE4
41 participants
INTERVENTIONAL
2007-01-31
2007-07-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
The Influence of Dietary Plant Sterols and Plant Stanols on Cholesterol and Plant Sterol Levels in Atheromatous Plaques
NCT00737919
Effect of Plant Stanol Esters on Blood Lipids
NCT00920894
Dietary Phytosterols and Human Aortic Valve
NCT00738933
Effect of Plant Stanols on Cholesterol Absorption
NCT00441857
Lipid-lowering Effect of Plant Stanol Drink
NCT01716390
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
CROSSOVER
TREATMENT
DOUBLE
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Intake of plant sterols
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Total cholesterol: 4.5-7.5 mmol/l
* Triglycerides at or below 4.0 mmol/l
Exclusion Criteria
* Secondary hyperlipidemia, included diabetes
* Hypertension (at og higher than 170/110)
* Coronar, perifery or cerebral vascular disease last 3 months
* Familial hypercholesterolemia
* Change in dose of statins, oestrogen or contraceptives last 3 months
* Taking drugs which are known to interfere with the plasma level of cholesterol
* Chronic rheumatoid diseases or other diseases known to affect c-reactive protein
* Pregnancy
* Lactation
* Planning to reduce weight
* Taking plant sterols
18 Years
80 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Mills DA
INDUSTRY
Oslo University Hospital
OTHER
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Leiv Ose, MD
Role: PRINCIPAL_INVESTIGATOR
Lipidklinikken, Rikshospitalet-Radiumhospitalet HF
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Lipidklinikken, Rikshospitalet Radiumhospitalet HF
Oslo, , Norway
Rikshospitalet Radiumhospitalet HF, Oslo, Norway
Oslo, , Norway
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Ottestad I, Ose L, Wennersberg MH, Granlund L, Kirkhus B, Retterstol K. Phytosterol capsules and serum cholesterol in hypercholesterolemia: a randomized controlled trial. Atherosclerosis. 2013 Jun;228(2):421-5. doi: 10.1016/j.atherosclerosis.2013.03.001. Epub 2013 Mar 20.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2.2006.3407
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.